OPK Opko Health Inc

$1.30

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 11/21/2025

About Opko Health Inc

OPKO Health, Inc., a healthcare company, is engaged in the pharmaceutical and diagnostic businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company is headquartered in Miami, Florida.

Website: https://www.opko.com

Sector
LIFE SCIENCES
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
944809
Address
4400 BISCAYNE BLVD., MIAMI, FL, US
Valuation
Market Cap
$1.13B
P/E Ratio
nan
PEG Ratio
-2.87
Price to Book
0.82
Performance
EPS
$-0.08
Dividend Yield
—
Profit Margin
-7.46%
ROE
-3.86%
Technicals
50D MA
$1.68
200D MA
$1.55
52W High
$2.04
52W Low
$1.15
Fundamentals
Shares Outstanding
793M
Target Price
$3.99
Beta
1.79

OPK EPS Estimates vs Actual

● Estimated
● Actual

OPK News & Sentiment

Nov 19, 2025 • GlobeNewswire NEUTRAL
OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference
MIAMI, Nov. 19, 2025 ( GLOBE NEWSWIRE ) -- OPKO Health, Inc. ( Nasdaq: OPK ) announced today that management will be participating in the Piper Sandler 37th Annual Healthcare Conference, being held December 2-4, 2025 at the Lotte New York Palace Hotel in New York City.
Nov 19, 2025 • Benzinga NEUTRAL
OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference - OPKO Health ( NASDAQ:OPK )
MIAMI, Nov. 19, 2025 ( GLOBE NEWSWIRE ) -- OPKO Health, Inc. ( NASDAQ:OPK ) announced today that management will be participating in the Piper Sandler 37th Annual Healthcare Conference, being held December 2-4, 2025 at the Lotte New York Palace Hotel in New York City.
Nov 18, 2025 • GlobeNewswire NEUTRAL
Entera Bio to Participate in the 8th Annual Evercore ISI Healthcare Conference
JERUSALEM, Nov. 18, 2025 ( GLOBE NEWSWIRE ) -- Entera Bio Ltd. ( Nasdaq: ENTX ) , ( "Entera" or the "Company" ) a leader in the development of oral peptide and protein replacement therapies, today announced that the Company's Chief Executive Officer, Miranda Toledano, will be participating in a ...
Nov 18, 2025 • Benzinga NEUTRAL
Entera Bio to Participate in the 8th Annual Evercore ISI Healthcare Conference - Entera Bio ( NASDAQ:ENTX )
JERUSALEM, Nov. 18, 2025 ( GLOBE NEWSWIRE ) -- Entera Bio Ltd. ( NASDAQ:ENTX ) , ( "Entera" or the "Company" ) a leader in the development of oral peptide and protein replacement therapies, today announced that the Company's Chief Executive Officer, Miranda Toledano, will be participating in a ...
Nov 14, 2025 • GlobeNewswire NEUTRAL
Entera Bio Announces Third Quarter 2025 Financial Results and Business Updates
FDA Agreement on BMD as Primary Endpoint for EB613 Registrational, Phase 3 Study ...
Nov 14, 2025 • Benzinga NEUTRAL
Entera Bio Announces Third Quarter 2025 Financial Results and Business Updates - Entera Bio ( NASDAQ:ENTX )
FDA Agreement on BMD as Primary Endpoint for EB613 Registrational, Phase 3 Study EB613 Phase 2 Data Demonstrating Consistent Efficacy across Younger Post-Menopausal Women with Osteoporosis and its Impact on Trabecular and Cortical Bone Indices, Highlighted at NAMS and ASBMR
Sentiment Snapshot

Average Sentiment Score:

0.070
50 articles with scored sentiment

Overall Sentiment:

Neutral

OPK Reported Earnings

Jul 31, 2025
Jun 30, 2025 (Pre market)
-0.08 Surprise
  • Reported EPS: $-0.19
  • Estimate: $-0.11
  • Whisper: —
  • Surprise %: -67.7%
Apr 30, 2025
Mar 31, 2025 (Pre market)
0.02 Surprise
  • Reported EPS: $-0.09
  • Estimate: $-0.11
  • Whisper: —
  • Surprise %: 13.7%
Feb 27, 2025
Dec 31, 2024 (Pre market)
0.11 Surprise
  • Reported EPS: $0.01
  • Estimate: $-0.10
  • Whisper: —
  • Surprise %: 110.0%
Nov 07, 2024
Sep 30, 2024 (Post market)
0.06 Surprise
  • Reported EPS: $-0.03
  • Estimate: $-0.09
  • Whisper: —
  • Surprise %: 66.7%
Aug 07, 2024
Jun 30, 2024 (Post market)
0.08 Surprise
  • Reported EPS: $-0.01
  • Estimate: $-0.09
  • Whisper: —
  • Surprise %: 88.9%
May 07, 2024
Mar 31, 2024 (Post market)
-0.03 Surprise
  • Reported EPS: $-0.12
  • Estimate: $-0.09
  • Whisper: —
  • Surprise %: -33.3%
Feb 27, 2024
Dec 31, 2023 (Post market)
0.0 Surprise
  • Reported EPS: $-0.09
  • Estimate: $-0.09
  • Whisper: —
  • Surprise %: 0.0%
Nov 06, 2023
Sep 30, 2023 (Post market)
-0.01 Surprise
  • Reported EPS: $-0.11
  • Estimate: $-0.10
  • Whisper: —
  • Surprise %: -10.0%
Aug 03, 2023
Jun 30, 2023 (Post market)
0.04 Surprise
  • Reported EPS: $-0.03
  • Estimate: $-0.07
  • Whisper: —
  • Surprise %: 57.1%

Financials